(Q45114522)

9 December 2017

Excitatory amino acids and Parkinson's disease (English)

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

30 October 2022

author name string

W. J. Schmidt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690929

30 October 2022

M. Bubser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690929

30 October 2022

W. Hauber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690929

30 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1690929

30 October 2022

publication date

1 February 1990

1 reference

full work available at URL

9 December 2017

https://api.elsevier.com/content/article/PII:016622369090066J?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

https://api.elsevier.com/content/article/PII:016622369090066J?httpAccept=text/plain

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

30 October 2022

published in

Trends in Neurosciences

1 reference

9 December 2017

13

1 reference

9 December 2017

2

1 reference

9 December 2017

46-47

1 reference

Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease

9 December 2017

1

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists

30 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

30 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

30 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine.

30 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

Systemic approaches to modifying quinolinic acid striatal lesions in rats

30 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors

30 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy

30 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

Behavioural effects of N-methyl-D-aspartate in the anterodorsal striatum of the rat.

30 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

30 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

30 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0166-2236(90)90066-J

30 October 2022

Identifiers

1 reference

9 December 2017

1 reference